Community-based, client-centered prevention homes to address the rural opioid epidemic
以社区为基础、以客户为中心的预防之家,解决农村阿片类药物流行问题
基本信息
- 批准号:10241935
- 负责人:
- 金额:$ 78.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-15 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAffectAntiviral AgentsAreaCase ManagementCase ManagerCharacteristicsClientClinicalCollaborationsCommunicable DiseasesCommunitiesCountyDataData CollectionEpidemicEpidemiologyEvaluationGeographyGoalsHIVHIV/HCVHarm ReductionHealth Information SystemHealth Service AreaHealth ServicesHepatitis C virusHeroinHomeIndividualInfectionInfrastructureInjecting drug userInterventionLegalMedicalMethodsMobile Health ApplicationModelingNamesNeedle-Exchange ProgramsNeeds AssessmentOpiate AddictionOpioidPharmaceutical PreparationsPhasePopulationPopulation SurveillancePrevalencePreventionProgram EffectivenessProviderPublic HealthQuantitative EvaluationsQuestionnairesResearchResourcesRespondentRiskRuralRural CommunityRural PopulationSamplingService delivery modelServicesSexually Transmitted DiseasesSiteSourceSyringesSystemTestingTimeTranslatingUnited StatesViral hepatitisWisconsinWorld Health Organizationbasecomorbidityethnographic methodevidence baseexperiencegeographic inaccessibilityhealth information technologyhigh riskimplementation frameworkimplementation scienceinnovationmHealthmarginalized populationmedication-assisted treatmentmeetingsnovelopioid abuseopioid abuse preventionopioid epidemicopioid injectionopioid mortalityopioid use disorderopioid userperson centeredprescription opioid abusepreventprevention servicepreventive interventionpublic health relevancerecruitresponserural countiesrural dwellersrural residenceservice coordinationservice deliverysuccesstreatment servicestrenduptake
项目摘要
PROJECT SUMMARY
In response to RFA-DA-17-014, HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid
Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control
(UG3/UH3), we propose a multi-phase, mixed-methods study that aims to implement and evaluate a novel
community response model, which we have named the Community-Based, Client-Centered Prevention Home.
Using the organizational infrastructure of a large, multi-site syringe service program serving a geographically
disperse population of people who inject drugs in rural communities across Northern Wisconsin, we will build
locally responsive systems to facilitate uptake of evidence-based prevention services for high-risk clients. The
Client-Centered Prevention Home model incorporates prevention case management and mobile health
information technology into traditional harm-reduction services delivered at syringe service programs, which we
hypothesize will increase use prevention services. During the UG3 phase, we will perform needs assessments
in 6 rural Wisconsin counties in partnership with local stakeholders, and use respondent driven sampling to
conduct a cross-sectional epidemiologic evaluation to estimate the prevalence of HIV, viral hepatitis and
sexually transmitted infections. Contingent upon meeting recruitment and data collection goals, in the UH3
phase of the project we will deploy and evaluate the Client-Centered Prevention Home model in the 3 counties
demonstrating highest vulnerability to worsening epidemics of opioid injection. The 3 remaining counties not
selected for implementation will serve as comparison sites in a quantitative evaluation of program effectiveness
during year 5. The growing problem of opioid injection in rural Wisconsin is highly significant because it
exemplifies trends observed nationally indicating severe vulnerability to worsening epidemics of HIV, HCV, and
opioid overdose deaths in rural communities that are substantially underserved by evidence-based prevention
interventions. This proposal is highly innovative because it will be the first study to use an evidence-based
mHealth strategy and a formal implementation science approach to enhance coordination of prevention
services in syringe service programs. It has potential for high impact because of our team's state-wide reach,
broad access to at-risk individuals, and robust infrastructure for conducting a rigorous, multi-site evaluation of
our proposed model.
项目摘要
回复RFA-DA-17-014,受阿片类药物影响的农村社区的HIV、HCV和相关合并症
美国的注射毒品流行病:建立预防、治疗和控制系统
(UG3/UH 3),我们提出了一个多阶段,混合方法的研究,旨在实施和评估一种新的
社区反应模式,我们称之为以社区为基础,以客户为中心的预防之家。
使用一个大型的、多地点的注射器服务项目的组织基础设施,
分散人口的人谁注射毒品在农村社区整个北方威斯康星州,我们将建立
地方应对系统,以促进高风险客户接受循证预防服务。的
以客户为中心的预防之家模式结合了预防病例管理和移动的保健
信息技术融入传统的减少伤害服务,在注射器服务计划,我们
假设将增加使用预防服务。在UG 3阶段,我们将进行需求评估
在6个农村威斯康星州县与当地利益相关者合作,并使用受访者驱动的抽样,
进行横断面流行病学评估,以估计艾滋病毒、病毒性肝炎和
性传播感染取决于是否达到UH 3中的招募和数据收集目标
在项目的第一阶段,我们将在3个县部署和评估以客户为中心的预防之家模式
这表明最容易受到阿片类药物注射流行病恶化的影响。剩下的三个县没有
在对计划的有效性进行定量评估时,
在第五年。在威斯康星州农村,阿片类药物注射问题日益严重,这一点非常重要,因为它
证实了在全国范围内观察到的趋势,表明艾滋病毒、丙型肝炎病毒和
农村社区阿片类药物过量死亡,循证预防服务严重不足
干预措施。这一建议具有高度的创新性,因为它将是第一项使用循证医学的研究。
移动卫生战略和正式实施科学方法,以加强预防协调
注射器服务计划中的服务。它有很大的影响力,因为我们的团队的全州范围内,
广泛接触处于风险中的个人,以及进行严格的多地点评估的强大基础设施
我们提出的模型。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Validation of Dried Blood Spots for Capturing Hepatitis C Virus Diversity for Genomic Surveillance.
验证干血斑捕获丙型肝炎病毒多样性以进行基因组监测。
- DOI:10.1101/2023.07.06.23292160
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Tully,DamienC;Power,KarenA;Sarette,Jacklyn;Stopka,ThomasJ;Friedmann,PeterD;Korthuis,PTodd;Cooper,Hannah;Young,AprilM;Seal,DavidW;Westergaard,RyanP;Allen,ToddM
- 通讯作者:Allen,ToddM
Predictors of skin and soft tissue infections among sample of rural residents who inject drugs.
注入药物的农村居民样本中皮肤和软组织感染的预测因子。
- DOI:10.1186/s12954-020-00447-3
- 发表时间:2020-12-02
- 期刊:
- 影响因子:4.4
- 作者:Baltes A;Akhtar W;Birstler J;Olson-Streed H;Eagen K;Seal D;Westergaard R;Brown R
- 通讯作者:Brown R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David W Seal其他文献
David W Seal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David W Seal', 18)}}的其他基金
Mobile health strategies to support longitudinal engagement in harm reduction services
支持纵向参与减少伤害服务的移动健康战略
- 批准号:
10590481 - 财政年份:2022
- 资助金额:
$ 78.82万 - 项目类别:
Community-based, client-centered prevention homes to address the rural opioid epidemic
以社区为基础、以客户为中心的预防之家,解决农村阿片类药物流行问题
- 批准号:
10195260 - 财政年份:2017
- 资助金额:
$ 78.82万 - 项目类别:
Community-based, client-centered prevention homes to address the rural opioid epidemic
以社区为基础、以客户为中心的预防之家,解决农村阿片类药物流行问题
- 批准号:
10642563 - 财政年份:2017
- 资助金额:
$ 78.82万 - 项目类别:
Community-based, client-centered prevention homes to address the rural opioid epidemic
以社区为基础、以客户为中心的预防之家,解决农村阿片类药物流行问题
- 批准号:
9760231 - 财政年份:2017
- 资助金额:
$ 78.82万 - 项目类别:
HIV Prevention Research and Infrastructure Development in Syria and Middle East
叙利亚和中东的艾滋病毒预防研究和基础设施发展
- 批准号:
8390302 - 财政年份:2010
- 资助金额:
$ 78.82万 - 项目类别:
HIV Prevention Research and Infrastructure Development in Syria and Middle East
叙利亚和中东的艾滋病毒预防研究和基础设施发展
- 批准号:
8011261 - 财政年份:2010
- 资助金额:
$ 78.82万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 78.82万 - 项目类别:
Research Grant